Windtree Therapeutics, Inc. (WINT) to Offer Common Stock

Go back to Windtree Therapeutics, Inc. (WINT) to Offer Common Stock

Windtree Therapeutics Announces Proposed Public Offering of Common Stock and Warrants

March 22, 2021 4:05 PM UTC

WARRINGTON, Pa., March 22, 2021 /PRNewswire/ -- Windtree Therapeutics, Inc. (NasdaqCM: WINT) ("Windtree" or the "Company"), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced that it has commenced an underwritten public offering of its shares of common stock and warrants to purchase shares of common stock. All of the shares of common stock and warrants in the offering will be sold by Windtree. The offering is subject to market conditions, and there can be no assurance as... More